Daniel DeNeui is a highly accomplished entrepreneur and executive known for his strategic prowess in business development, executive coaching, and his insightful application of human behavior and psychology in the workplace. His adeptness in public speaking has further propelled his success, allowing him to establish and nurture several multi-million dollar ventures from their inception with only modest initial investments.

As the CEO of EVEXIAS Health Solutions®, Daniel has been instrumental in redefining the landscape of medical wellness. His innovative approach has rejuvenated the enthusiasm and effectiveness of healthcare practitioners, enhancing the quality of patient care.

In collaboration with his spouse, Daniel steers the overarching strategy of EVEXIAS and its affiliate FarmaKeio, focusing on revolutionizing healthcare through expanding educational programs and introducing groundbreaking therapeutic and business solutions. Since taking on his role in 2015, his rich science and business management background has enabled significant growth in the company’s offerings, such as the EvexiPEL® Method, PeptideSolutions™, and NutraceuticalSolutions™.

At EVEXIAS, Daniel is committed to developing tailored wellness plans incorporating an integrative, functional approach to health care. These plans aim to address the foundational causes of health issues, mainly focusing on hormonal imbalances. He oversees the implementation of advanced treatment options, including bioidentical hormone replacement therapy and specialized nutraceutical supplements, ensuring these interventions are personalized to meet each patient's needs.

Under his leadership, EVEXIAS has also made significant strides in adopting new technologies to support the professional growth of healthcare providers. In 2022, Daniel launched EVEXIAS Online, an advanced platform designed to enhance interaction among healthcare professionals by facilitating the sharing of insights, complex case discussions, and access to comprehensive educational resources. Additionally, in early 2023, he managed the organization’s largest-ever training event, which focused on practical skills in hormone therapy, greatly enhancing the capabilities of participating practitioners.

Before his current role, Daniel held impactful positions at Asperio Labs and BioTE Medical, where he focused on hormone optimization and promoting healthy aging. His earlier career included significant leadership roles at Independent Producers of America and Cornerstone America, where he was essential in developing strategic sales and business initiatives.

Daniel DeNeui's education in organic chemistry from Clemson University has provided a robust foundation for his professional achievements, blending scientific knowledge with executive leadership. Beyond his business commitments, he is an active philanthropist, supporting charitable organizations that assist families facing unexpected challenges.